文献速递产科母胎医学

产时吸氧对剖宫产率影响的荟萃分析

Effect of intrapartum oxygen on the rate of cesarean delivery: a meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-04-06

该系统评价与荟萃分析纳入5项随机对照试验共768名产妇,比较产时吸氧与室内空气对剖宫产率的影响。结果显示两组剖宫产率无统计学显著差异(4.4% vs 2.9%;RR 1.5;95%CI 0.7-3.3),次要母婴结局亦无显著差异。

要点

  • 产时吸氧与室内空气相比,剖宫产率无显著差异。
  • 治疗性或预防性吸氧亚组分析均未显示剖宫产率差异。
  • 现有证据不支持产时常规吸氧以降低剖宫产率。

核心结论

  • 产时吸氧与室内空气相比,剖宫产率及次要母婴结局均无显著差异。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、OVID、Scopus、ClinicalTrials.gov和Cochrane Central Register of Controlled Trials至2020年4月。
  • 纳入5项随机对照试验共768名产妇,其中3项为预防性吸氧,2项为胎心监护异常时吸氧。
  • 采用Cochrane手册评估偏倚,随机效应模型计算相对风险或均数差及置信区间。

主要发现

  • 剖宫产率吸氧组16/365(4.4%) vs 室内空气组11/379(2.9%),RR 1.5,95%CI 0.7-3.3,无统计学显著差异。
  • 因胎心监护异常行剖宫产率、器械助产率、Apgar评分<7、新生儿ICU入住率及脐血气值均无统计学显著差异。
  • 单独分析胎心监护异常时吸氧或预防性吸氧,均无统计学显著差异。

关键数值与推荐

  • 纳入标准:产时吸氧与室内空气比较的随机对照试验;排除准随机试验和计划性剖宫产时的吸氧。
  • 主要结局为剖宫产率;次要结局包括母婴结局及脐血气值。

临床怎么用

  • 产时吸氧不应常规用于降低剖宫产率,需根据临床指征个体化决策。
  • 对于胎心监护异常,吸氧的获益尚不明确,需结合其他干预措施。

局限性

  • 纳入研究数量少(5项),样本量有限(768例),可能不足以检测小效应。
  • 需要大型随机对照试验进一步评估产时吸氧的潜在获益或危害。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to determine if maternal intrapartum administration of oxygen altered the rate of cesarean delivery compared with room air. DATA SOURCES: This study was a systematic review and meta-analysis of randomized controlled trials. Searches were performed in MEDLINE, OVID, Scopus, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials using a combination of key words related to "pregnant patients," "labor," "oxygen," "fetus," "newborn," and pregnancy outcomes from database inception until April 2020. The study was registered in PROSPERO (registration number CRD42020162110). STUDY ELIGIBILITY CRITERIA: The inclusion criteria were randomized controlled trials of maternal administration of oxygen compared with room air in labor. The exclusion criteria were quasi-randomized trials and oxygen administered for planned cesarean deliveries. The primary outcome was the rate of cesarean delivery. Secondary maternal and neonatal outcomes, including cord gas values, were analyzed. METHODS: The Cochrane Handbook guidelines were used to assess bias in trials. To calculate the relative risk or mean differences with confidence intervals, a random-effects model was employed. Subgroup analyses were performed for women who received oxygen for nonreassuring fetal heart rate monitoring or prophylactically. RESULTS: Five randomized controlled trials, including 768 women, were included in the meta-analysis, 3 using prophylactic oxygen and 2 using oxygen for nonreassuring fetal heart rate monitoring. The risk of bias was generally considered low. There was no statistically significant difference in the rate of cesarean delivery between patients administered oxygen and patients provided room air (16 of 365 [4.4%] vs 11 of 379 [2.9%]; risk ratio 1.5; 95% confidence interval, 0.7-3.3). In addition, there were no statistically significant differencs in the rates of cesarean delivery for nonreassuring fetal heart rate monitoring, operative vaginal deliveries, Apgar scores of <7, neonatal intensive care unit admissions, or cord blood gas values. There were no statistically significant difference when analyzing oxygen for nonreassuring fetal heart rate monitoring alone or prophylactic oxygen alone. Data regarding FHT is mixed, with one study suggesting an improvement and three suggesting no change. CONCLUSION: Maternal intrapartum oxygen administration was not associated with any differences in the rate of cesarean delivery or any secondary outcomes compared with room air overall and in the subgroups of therapeutic (for nonreassuring fetal heart rate monitoring) or prophylactic administration in this meta-analysis. Large randomized controlled trials are necessary to further examine any possible benefits or harms of oxygen administration in labor, particularly for nonreassuring fetal heart rate monitoring.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Burd J, Quist-Nelson J, Moors S, et al. Effect of intrapartum oxygen on the rate of cesarean delivery: a meta-analysis. Am J Obstet Gynecol MFM. 2021. PMID: 33836306. doi:10.1016/j.ajogmf.2021.100374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。